These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23874169)

  • 1. Target essentiality and centrality characterize drug side effects.
    Wang X; Thijssen B; Yu H
    PLoS Comput Biol; 2013; 9(7):e1003119. PubMed ID: 23874169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets of drugs are generally, and targets of drugs having side effects are specifically good spreaders of human interactome perturbations.
    Perez-Lopez ÁR; Szalay KZ; Türei D; Módos D; Lenti K; Korcsmáros T; Csermely P
    Sci Rep; 2015 May; 5():10182. PubMed ID: 25960144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized network centrality and essentiality in the yeast-protein interaction network.
    Park K; Kim D
    Proteomics; 2009 Nov; 9(22):5143-54. PubMed ID: 19771559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network neighbors of drug targets contribute to drug side-effect similarity.
    Brouwers L; Iskar M; Zeller G; van Noort V; Bork P
    PLoS One; 2011; 6(7):e22187. PubMed ID: 21765950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Analyses and Prediction of Human Drug Side Effect Associated Proteins from the Perspective of Protein Evolution.
    Begum T; Ghosh TC; Basak S
    Genome Biol Evol; 2017 Feb; 9(2):337-350. PubMed ID: 28391292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ensemble framework for identifying essential proteins.
    Zhang X; Xiao W; Acencio ML; Lemke N; Wang X
    BMC Bioinformatics; 2016 Aug; 17(1):322. PubMed ID: 27557880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Adverse Reaction Target Database (DART) : proteins related to adverse drug reactions.
    Ji ZL; Han LY; Yap CW; Sun LZ; Chen X; Chen YZ
    Drug Saf; 2003; 26(10):685-90. PubMed ID: 12862503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel paradigm for potential drug-targets discovery: quantifying relationships of enzymes and cascade interactions of neighboring biological processes to identify drug-targets.
    Chen L; Wang Q; Zhang L; Tai J; Wang H; Li W; Li X; He W; Li X
    Mol Biosyst; 2011 Apr; 7(4):1033-41. PubMed ID: 21270979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network-based characterization of drug-regulated genes, drug targets, and toxicity.
    Kotlyar M; Fortney K; Jurisica I
    Methods; 2012 Aug; 57(4):499-507. PubMed ID: 22749929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive prediction of drug-protein interactions and side effects for the human proteome.
    Zhou H; Gao M; Skolnick J
    Sci Rep; 2015 Jun; 5():11090. PubMed ID: 26057345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Genome and Network Centrality Analysis to Identify Drug Targets of Mycobacterium tuberculosis H37Rv.
    Melak T; Gakkhar S
    Biomed Res Int; 2015; 2015():212061. PubMed ID: 26618166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug combinatorics and side effect estimation on the signed human drug-target network.
    Torres NB; Altafini C
    BMC Syst Biol; 2016 Aug; 10(1):74. PubMed ID: 27526853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A local average connectivity-based method for identifying essential proteins from the network level.
    Li M; Wang J; Chen X; Wang H; Pan Y
    Comput Biol Chem; 2011 Jun; 35(3):143-50. PubMed ID: 21704260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ultra-fast 2D and 3D ligand and target descriptors for side effect prediction and network analysis in polypharmacology.
    Cortés-Cabrera A; Morris GM; Finn PW; Morreale A; Gago F
    Br J Pharmacol; 2013 Oct; 170(3):557-67. PubMed ID: 23826885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach.
    Liu T; Altman RB
    J Chem Inf Model; 2015 Jul; 55(7):1483-94. PubMed ID: 26121262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between rational drug design and drug side effects.
    Wang J; Li ZX; Qiu CX; Wang D; Cui QH
    Brief Bioinform; 2012 May; 13(3):377-82. PubMed ID: 21949217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.
    Chartier M; Morency LP; Zylber MI; Najmanovich RJ
    BMC Pharmacol Toxicol; 2017 Apr; 18(1):18. PubMed ID: 28449705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building the process-drug-side effect network to discover the relationship between biological processes and side effects.
    Lee S; Lee KH; Song M; Lee D
    BMC Bioinformatics; 2011 Mar; 12 Suppl 2(Suppl 2):S2. PubMed ID: 21489221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond degree and betweenness centrality: Alternative topological measures to predict viral targets.
    Devkota P; Danzi MC; Wuchty S
    PLoS One; 2018; 13(5):e0197595. PubMed ID: 29795705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relating drug-protein interaction network with drug side effects.
    Mizutani S; Pauwels E; Stoven V; Goto S; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i522-i528. PubMed ID: 22962476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.